This is a preview of subscription content, log in via an institution to check access.
Reference
Qin J, et al. TCM monotherapy achieves significant efficacy in crizotinib-refractory advanced NSCLC with brain metastasis. Medicine 102 : 1-5, No. 29, Jul 2023. Available from: URL: http://doi.org/10.1097/MD.0000000000034138
Rights and permissions
About this article
Cite this article
Alectinib/crizotinib. Reactions Weekly 1977, 21 (2023). https://doi.org/10.1007/s40278-023-47095-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-47095-5